AVIVA PLC – Regeneron Pharmaceuticals, Inc. Transaction History
AVIVA PLC portfolio value:
$26.04M
portfolio value
AVIVA PLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.37% | -1.31K shares | 2.91M | $688.87 | 37.80K |
| Q2 2022 | share | Increase | +46.41% | 12.40K shares | 4.46M | $591.13 | 39.12K |
| Q1 2022 | share | Decrease | -14.43% | -4.50K shares | -1.05M | $698.42 | 26.72K |
| Q4 2021 | share | Increase | +1.79% | 549 shares | 1.15M | $642.51 | 31.23K |
| Q3 2021 | share | Decrease | -4.81% | -1.55K shares | 566K | $605.18 | 30.68K |
| Q2 2021 | share | Increase | +0.31% | 101 shares | 2.8M | $558.54 | 32.23K |
| Q1 2021 | share | Increase | +0.90% | 287 shares | -182K | $473.14 | 32.13K |
| Q4 2020 | share | Increase | +2.24% | 697 shares | -2.05M | $483.11 | 31.84K |
| Q3 2020 | share | Decrease | -2.65% | -848 shares | -2.51M | $559.78 | 31.14K |
| Q2 2020 | share | Increase | +68.34% | 12.98K shares | 10.67M | $623.65 | 31.99K |
| Q1 2020 | share | Decrease | -2.39% | -466 shares | 1.96M | $488.29 | 19.00K |
| Q4 2019 | share | Decrease | -4.58% | -935 shares | 1.65M | $375.48 | 19.47K |
| Q3 2019 | share | Decrease | -32.23% | -9.70K shares | -3.76M | $277.4 | 20.40K |
| Q2 2019 | share | Decrease | -1.02% | -311 shares | -3.06M | $313 | 30.11K |
| Q1 2019 | share | Increase | +1.29% | 386 shares | 1.27M | $410.62 | 30.42K |
| Q4 2018 | share | Decrease | -21.78% | -8.36K shares | -4.29M | $373.5 | 30.03K |
| Q3 2018 | share | Decrease | -3.83% | -1.53K shares | 1.73M | $404.04 | 38.39K |
| Q2 2018 | share | Decrease | -0.91% | -368 shares | -102K | $344.99 | 39.92K |
| Q1 2018 | share | Decrease | -8.87% | -3.92K shares | -2.74M | $344.36 | 40.29K |
| Q4 2017 | share | Decrease | -11.29% | -5.62K shares | -5.65M | $375.96 | 44.22K |
| Q3 2017 | share | Decrease | -0.18% | -90 shares | -2.24M | $447.12 | 49.84K |
| Q2 2017 | share | Decrease | -2.19% | -1.12K shares | 4.74M | $491.14 | 49.93K |
| Q1 2017 | share | Decrease | -4.22% | -2.24K shares | 205K | $387.51 | 51.05K |
| Q4 2016 | share | Increase | +6.61% | 3.30K shares | -525K | $367.09 | 53.30K |
| Q3 2016 | share | Increase | +1.10% | 545 shares | 2.82M | $402.02 | 50K |
| Q2 2016 | share | Increase | +10.37% | 4.64K shares | 1.12M | $349.23 | 49.45K |
| Q1 2016 | share | Increase | +2.98% | 1.29K shares | -7.47M | $360.44 | 44.80K |